White blood cells (WBCs), also known as leukocytes, are a heterogeneous group of nucleated cells that circulate in the blood and comprise a central component of the vertebrate immune system. They are distinguished from erythrocytes (red blood cells) and thrombocytes (platelets) by the presence of a nucleus and by their role in defending the host against infectious agents, foreign substances, and malignant cells. In humans, normal circulating leukocyte concentrations range from approximately 4,000 to 11,000 cells per microliter of blood, though values can vary with age, sex, physiological conditions, and pathological states.
Classification
Leukocytes are traditionally classified into two broad categories based on the presence of granules in their cytoplasm:
-
Granulocytes – characterized by abundant cytoplasmic granules that stain readily with Romanowsky-type dyes. Subtypes include:
- Neutrophils: The most abundant leukocyte (≈50–70 % of total WBCs). They are primary responders to bacterial infections and execute phagocytosis, degranulation, and the formation of neutrophil extracellular traps (NETs).
- Eosinophils: Involved in responses to parasitic helminths and in allergic inflammation; they contain granules rich in major basic protein and eosinophil peroxidase.
- Basophils: The least common granulocyte; they release histamine, heparin, and cytokines during hypersensitivity reactions and inflammatory processes.
-
Agranulocytes – lack visible cytoplasmic granules and include:
- Lymphocytes: Subdivided into B cells (responsible for humoral immunity via antibody production), T cells (mediating cell‑mediated immunity, including helper, cytotoxic, regulatory, and memory subsets), and natural killer (NK) cells (involved in innate cytotoxic responses).
- Monocytes: Large phagocytic cells that circulate in the blood and differentiate into macrophages or dendritic cells upon migration into tissues. They play pivotal roles in antigen presentation, cytokine production, and tissue remodeling.
Development and Regulation
Leukocytes are derived from hematopoietic stem cells (HSCs) located in the bone marrow. Differentiation follows a hierarchical lineage model, with specific growth factors and cytokines—such as granulocyte colony‑stimulating factor (G‑CSF), macrophage colony‑stimulating factor (M‑CSF), interleukin‑3 (IL‑3), and interleukin‑7 (IL‑7)—directing lineage commitment. The process, termed leukopoiesis, is tightly regulated to maintain homeostasis and respond to systemic demands (e.g., infection, tissue injury).
Functional Roles
- Host Defense: Leukocytes identify and eliminate pathogens through mechanisms including phagocytosis (neutrophils, monocytes/macrophages), antibody‑dependent cellular cytotoxicity (NK cells, certain T cells), and the release of antimicrobial peptides and reactive oxygen species.
- Immune Regulation: Lymphocytes and monocytes/macrophages secrete cytokines and chemokines that orchestrate the innate and adaptive immune responses, influencing inflammation, tissue repair, and resolution of immune reactions.
- Surveillance and Homeostasis: Certain leukocyte subsets (e.g., dendritic cells) continuously sample antigens and maintain tolerance to self‑antigens, thereby preventing autoimmunity. Monocytes/macrophages participate in the clearance of apoptotic cells and cellular debris.
Clinical Significance
- Leukocytosis: An elevated leukocyte count, often indicative of infection, inflammation, stress, hematologic malignancies (e.g., chronic leukemias), or corticosteroid therapy.
- Leukopenia: Reduced leukocyte numbers, which may predispose individuals to opportunistic infections; causes include bone marrow suppression (e.g., chemotherapy, aplastic anemia), viral infections (e.g., HIV), and certain autoimmune disorders.
- Differential Diagnosis: A complete blood count (CBC) with differential quantifies each leukocyte subtype, aiding in diagnosing specific conditions such as eosinophilia (allergic disease, parasitosis), neutropenia (chemotherapy, congenital neutropenia), or lymphocytosis (viral infections, chronic lymphocytic leukemia).
- Therapeutic Interventions: Agents like G‑CSF are employed clinically to stimulate neutrophil production in neutropenic patients. Immunomodulatory therapies target specific leukocyte pathways (e.g., monoclonal antibodies against CD20 deplete B cells in certain lymphomas).
Historical Context
The term “leukocyte” derives from the Greek words leukos (“white”) and kytos (“cell”). Early microscopic studies in the 19th century identified distinct leukocyte types, leading to the modern classification system based on staining characteristics and functional attributes.
Research Directions
Current investigations focus on delineating leukocyte heterogeneity using high‑dimensional single‑cell technologies (e.g., flow cytometry, scRNA‑seq), elucidating the mechanisms of leukocyte trafficking across vascular barriers, and developing cell‑based immunotherapies (e.g., chimeric antigen receptor T cells) that harness the specificity and cytotoxic capabilities of leukocytes.
This entry reflects the current consensus in biomedical literature as of 2026.